149 related articles for article (PubMed ID: 10765148)
1. Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules.
Poehlau D; Kiltz U; Rieks M; Hoffmann V; Rebmann V; Schimrigk S; Grosse-Wilde H; Przuntek H
Vox Sang; 2000; 78(2):119-21. PubMed ID: 10765148
[TBL] [Abstract][Full Text] [Related]
2. Influence of anticoagulants on the level of soluble HLA class I and class II antigens measured in blood samples.
Hausmann S; Claus R; Falk U; Wegener S
J Immunoassay; 1996 Aug; 17(3):257-75. PubMed ID: 8842984
[TBL] [Abstract][Full Text] [Related]
3. Comparison of soluble and membrane bound HLA-class I and DR levels in umbilical cord blood and adult peripheral blood.
Higuchi A; Hagihara M; Tsumuraya N; Gansuvd B; Kato S; Hotta T
Tokai J Exp Clin Med; 2003 Apr; 28(1):1-7. PubMed ID: 12880297
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitis.
Heiligenhaus A; Rebmann V; Neubert A; Plewa S; Ferencik S; Vögeler U; Steuhl KP; Grosse-Wilde H
Tissue Antigens; 2004 Apr; 63(4):369-75. PubMed ID: 15009809
[TBL] [Abstract][Full Text] [Related]
5. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA-G in rheumatoid arthritis.
Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients.
Mathew JM; Shenoy S; Phelan D; Lowell J; Howard T; Mohanakumar T
Transplantation; 1996 Jul; 62(2):217-23. PubMed ID: 8755819
[TBL] [Abstract][Full Text] [Related]
8. Plasma soluble human leukocyte antigen G levels in asthmatic children.
Tahan F; Patiroglu T
Int Arch Allergy Immunol; 2006; 141(3):213-6. PubMed ID: 16926540
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA levels in early pregnancy after in vitro fertilization.
Pfeiffer KA; Rebmann V; Pässler M; van der Ven K; van der Ven H; Krebs D; Grosse-Wilde H
Hum Immunol; 2000 Jun; 61(6):559-64. PubMed ID: 10825584
[TBL] [Abstract][Full Text] [Related]
10. Association of soluble HLA-G plasma levels with HLA-G alleles.
Rebmann V; van der Ven K; Pässler M; Pfeiffer K; Krebs D; Grosse-Wilde H
Tissue Antigens; 2001 Jan; 57(1):15-21. PubMed ID: 11169254
[TBL] [Abstract][Full Text] [Related]
11. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
12. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors.
Lindemann M; Rebmann V; Ottinger HD; Schmolke K; Kreuzfelder E; Grosse-Wilde H
Exp Hematol; 2004 Nov; 32(11):1103-9. PubMed ID: 15539089
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of soluble HLA-DR antigens in human serum and other body fluids.
Hausmann S; Claus R; Buchwald S; Köhler H; Hausmann D; Falk U; Wegener S
Beitr Infusionsther Transfusionsmed; 1994; 32():281-7. PubMed ID: 9422113
[TBL] [Abstract][Full Text] [Related]
14. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G
Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112
[TBL] [Abstract][Full Text] [Related]
16. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation.
Filaci G; Contini P; Brenci S; Lanza L; Scudeletti M; Indiveri F; Puppo F
Tissue Antigens; 1995 Aug; 46(2):117-23. PubMed ID: 7482504
[TBL] [Abstract][Full Text] [Related]
17. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
[TBL] [Abstract][Full Text] [Related]
18. Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients.
Rebmann V; Ugurel S; Tilgen W; Reinhold U; Grosse-Wilde H
Int J Cancer; 2002 Aug; 100(5):580-5. PubMed ID: 12124808
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
20. Impact of blood processing on estimation of soluble HLA-G.
Poláková K; Bandžuchová E; Russ G
Neoplasma; 2011; 58(4):337-42. PubMed ID: 21520991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
